Evidence map›Paper›PMID 40045743›Full record

ArticleTurkish journal of haematology : official journal of Turkish Society of Haematology2025

Retrospective Evaluation of Clinical and Follow-Up Outcomes in Primary Cutaneous CD30

Hatice Şanlı, Ahmet Taha Aydemir, İncilay Kalay Yıldızhan, Aylin Heper, Işınsu Kuzu, Ayça Kırmızı, Ayşenur Botsalı, Bengü Nisa Akay

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish journal of haematology : official journal of Turkish Society of Haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hatice ŞanlıAnkara University Faculty of Medicine, Department of Dermatology and Venereal Diseases, Ankara, TürkiyeORCID 0000-0002-2960-3126
Ahmet Taha AydemirAnkara University Faculty of Medicine, Department of Dermatology and Venereal Diseases, Ankara, TürkiyeORCID 0000-0003-4061-8094
İncilay Kalay YıldızhanAnkara University Faculty of Medicine, Department of Dermatology and Venereal Diseases, Ankara, TürkiyeORCID 0000-0002-5289-4857
Aylin HeperAnkara University Faculty of Medicine, Department of Pathology, Ankara, TürkiyeORCID 0000-0002-7807-0717
Işınsu KuzuAnkara University Faculty of Medicine, Department of Pathology, Ankara, TürkiyeORCID 0000-0001-5519-1009
Ayça KırmızıAnkara University Faculty of Medicine, Department of Pathology, Ankara, TürkiyeORCID 0000-0003-3192-1921
Ayşenur BotsalıUniversity of Health Sciences Türkiye, Gülhane Training and Research Hospital, Clinic of Dermatology and Venereal Diseases, Ankara, TürkiyeORCID 0000-0001-9431-2125
Bengü Nisa AkayAnkara University Faculty of Medicine, Department of Dermatology and Venereal Diseases, Ankara, TürkiyeORCID 0000-0002-4896-1666

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the demographic data, clinical characteristics, treatment approaches, and treatment responses of 43 patients with primary cutaneous CD30

Indexed as

Ki-1 AntigenLymphomatoid PapulosisLymphoproliferative DisordersSkin NeoplasmsAdolescentAdultAgedAged, 80 and overFemaleFollow-Up StudiesHumansLymphoma, Primary Cutaneous Anaplastic Large CellMaleMiddle AgedRetrospective StudiesTreatment OutcomeKi-1 AntigenLymphomatoid papulosisPrimary cutaneous anaplastic large-cell lymphomaPrimary cutaneous CD30+ lymphoproliferative disorders

Identifiers

PMID40045743
PMCPMC12099482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.